Aducanumab: European agency rejects Alzheimer’s drug over efficacy and safety concerns

Published 2021 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Aducanumab: European agency rejects Alzheimer’s drug over efficacy and safety concerns
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages n3127
Publisher
BMJ
Online
2021-12-21
DOI
10.1136/bmj.n3127
References
View 4 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.